{
    "Trade/Device Name(s)": [
        "CONTOUR\u00aeNEXT Blood Glucose Monitoring System",
        "CONTOUR\u00aeNEXT Test Strips",
        "CONTOUR\u00aeNEXT Control Solutions"
    ],
    "Submitter Information": "Bayer Healthcare LLC",
    "510(k) Number": "K121190",
    "Predicate Device Reference 510(k) Number(s)": [
        "K110894"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "LFR",
        "JJX"
    ],
    "Summary Letter Date": "June 28, 2012",
    "Summary Letter Received Date": "June 29, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Whole Blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "CONTOUR\u00aeNEXT Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Dry reagent test strips",
        "Electrochemical measurement"
    ],
    "Methodologies": [
        "Quantitative measurement"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Test Strip",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for CONTOUR\u00aeNEXT Blood Glucose Monitoring System for home glucose measurement in whole blood using dry reagent strips and controls",
    "Indications for Use Summary": "Over the counter, single-patient home monitoring device for quantitative measurement of glucose in fresh capillary whole blood from fingertip and palm, not for diagnosis or neonatal use",
    "fda_folder": "Clinical Chemistry"
}